Are there any specific research areas that are excluded from GLOBAL ASPIRE TTR Amyloidosis Research funding?

Are there any specific research areas that are excluded from GLOBAL ASPIRE TTR Amyloidosis Research funding?

The following topics fall outside of the scope of the GLOBAL ASPIRE TTR Amyloidosis Research Program:

  • Studies involving requests for formulated study drug or pure substance
  • Public health
  • Support for ongoing clinical programs that are part of an organization’s routine operations
  • Studies designed to address how patients / payers use evidence about our products to make coverage and reimbursement decisions are prohibited
  • Studies focused on progression of disease with attention to burden of disease and health outcomes
  • Head to head drug studies
  • Anything outside of TTR amyloidosis
  • Dose-response or combination therapy studies
  • Pediatric investigations
  • End stage disease (Stage 3-4 TTR amyloidosis)
  • Pre-clinical studies (except requests for pure substance only)
  • Post-transplant investigations (top)

FAQ Category:

FAQ Tag: 
excludedareas